2018
DOI: 10.1093/eurheartj/ehy563.p3508
|View full text |Cite
|
Sign up to set email alerts
|

P3508Cardiac iodine-123 metaiodobenzylguanidine imaging predicts frequent hypotension during hemodialysis in patients with end-stage renal disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2020
2020

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…From 1997, 123 I‐2beta‐carboxymethoxy‐3beta‐[4‐iodophenyl] tropane ( 123 I‐ beta ‐CIT) was employed to measure dopamine transporters aiding in the diagnosis of Parkinson's disease 4 . Over the last few decades, there has been an increase in interest in 123 I‐metaiodobenzylguanidine (MIBG) being used for imaging tumours of neuroendocrine origin such as neuroblastoma and phaeochromocytoma and for cardiac imaging 5,6 …”
Section: Introductionmentioning
confidence: 99%
“…From 1997, 123 I‐2beta‐carboxymethoxy‐3beta‐[4‐iodophenyl] tropane ( 123 I‐ beta ‐CIT) was employed to measure dopamine transporters aiding in the diagnosis of Parkinson's disease 4 . Over the last few decades, there has been an increase in interest in 123 I‐metaiodobenzylguanidine (MIBG) being used for imaging tumours of neuroendocrine origin such as neuroblastoma and phaeochromocytoma and for cardiac imaging 5,6 …”
Section: Introductionmentioning
confidence: 99%